Business
Earth Science Tech Engages Consultant to Lead Dual Listing Compliance
Earth Science Tech Engages Consultant to Lead Dual Listing Compliance.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\nDORAL, Florida, March 07, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces that it has engaged Derek Lindsay as a consultant to manage compliance for the potential dual listing of the Company’s common shares on the Canadian Securities Exchange (the “CSE”) in addition to its current listing on the OTCQB.\n Derek Lindsay assist ETST with the listing process on the CSE as previously announced by the Company and will implement an investor relation program and other items. “Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” stated Mr. Lindsay. “Considering that ETST’s R&D division is based in Canada, cross-listing appears well-aligned with the corporate vision. Once this milestone is complete, ongoing efforts will be needed to monitor and ensure compliance, build shareholder value, and communicate with investors. I look forward to supporting the Company in these endeavors.” Derek Lindsay has solid experience in accelerating the growth of emerging private and public companies, serving as in various capacities that include investor, member of the management team or on the board of directors. His expertise includes capital raising, strategic advice, investor relations and risk management. ETST President and Chairman Nickolas Tabraue, stated, “We believe Derek’s expertise makes him the perfect fit to ensure that we improve communication with our shareholders and progress on the CSE listing. I plan on sharing further updates as we advance this initiative.” About Earth Science Tech, Inc. (ETST)Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distribu...